Incidence and diagnosis of pertussis in South African children hospitalized with lower respiratory tract infection

Pediatric Infectious Disease Journal

Volumn 35, Issue 6, 2016, Pages 611-616

  Muloiwa, Rudzani ^a   Dube, Felix S ^b   Nicol, Mark P ^b,c,d   Zar, Heather J ^a   Hussey, Gregory D ^a,d  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b UNIVERSITY OF CAPE TOWN   (South Africa)

^c UNIVERSITY OF CAPE TOWN   (South Africa)

^d Desmond Tutu HIV Centre   (South Africa)

Author keywords

Bordetella parapertussis; Bordetella pertussis; induced sputum; pertussis; Respiratory infection

Indexed keywords

CEFTRIAXONE; COTRIMOXAZOLE; DIPHTHERIA PERTUSSIS TETANUS VACCINE; ERYTHROMYCIN; PENICILLIN DERIVATIVE;

ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL GROWTH; BACTERIUM DETECTION; BORDETELLA PARAPERTUSSIS; BORDETELLA PERTUSSIS; BRONCHIOLITIS; BRONCHOPNEUMONIA; CHILD; CHILD HOSPITALIZATION; CHILDHOOD DISEASE; CONTROLLED STUDY; DIAGNOSTIC VALUE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNIZATION; INCIDENCE; INFANT; LENGTH OF STAY; LOWER RESPIRATORY TRACT INFECTION; MAJOR CLINICAL STUDY; MALE; NONHUMAN; NOSE SMEAR; PERTUSSIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; SOUTH AFRICAN; SPUTUM ANALYSIS; HOSPITALIZATION; ISOLATION AND PURIFICATION; MICROBIOLOGY; NASOPHARYNX; NEWBORN; PRESCHOOL CHILD; RESPIRATORY TRACT INFECTIONS; SOUTH AFRICA; SPUTUM; WHOOPING COUGH;

BORDETELLA PARAPERTUSSIS; BORDETELLA PERTUSSIS; CHILD; CHILD, PRESCHOOL; FEMALE; HOSPITALIZATION; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; MALE; NASOPHARYNX; POLYMERASE CHAIN REACTION; PROSPECTIVE STUDIES; RESPIRATORY TRACT INFECTIONS; SOUTH AFRICA; SPUTUM; WHOOPING COUGH;

EID: 84960458166     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0000000000001132     Document Type: Article

References (36)

1. Mattoo S, Cherry JD. Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies. Clin Microbiol Rev. 2005;18:326-382.
2. Crowcroft NS, Stein C, Duclos P, et al. How best to estimate the global burden of pertussis? Lancet Infect Dis. 2003;3:413-418.
3. World Health Organisation. Managing pertussis outbreaks during humanitarian emergencies. Geneva, Switzerland: World Health Organisation; 2008:3.
4. Cherry JD. Pertussis: challenges today and for the future. PLoS Pathog. 2013;9:e1003418.
5. Wood N, McIntyre P. Pertussis: review of epidemiology, diagnosis, management and prevention. Paediatr Respir Rev. 2008;9:201-211; quiz 211-202.
6. Cherry JD, Tan T, Wirsing von Konig CH, et al. Clinical definitions of pertussis: Summary of a Global Pertussis Initiative roundtable meeting, February 2011. Clin Infect Dis. 2012;54:1756-1764.
7. Fry NK, Tzivra O, Li YT, et al. Laboratory diagnosis of pertussis infections: The role of PCR and serology. J Med Microbiol. 2004;53(pt 6):519-525.
8. Riffelmann M, Wirsing von König CH, Caro V, et al.; Pertussis PCR Consesus Group. Nucleic Acid amplification tests for diagnosis of Bordetella infections. J Clin Microbiol. 2005;43:4925-4929.
9. Crowcroft NS, Pebody RG. Recent developments in pertussis. Lancet. 2006;367:1926-1936.
10. Gregory DS. Pertussis: A disease affecting all ages. Am Fam Physician. 2006;74:420-426.
11. Singh M, Lingappan K. Whooping cough: The current scene. Chest. 2006;130:1547-1553.
12. World Health Organisation. WHO-recommended surveillance standard of pertussis. Available at: http://www.who.int/immunization/monitoring-surveillance/burden/vpd/surveillance-type/passive/pertussis-standards/en/. Accessed June 28, 2015.
13. Ngcobo NJ. New EPI vaccines guidelines. Pretoria, South Africa: National Department of Health; 2010:1-15.
14. Corrigall J, Coetzee D, Cameron N. Is the Western Cape at risk of an outbreak of preventable childhood diseases? Lessons from an evaluation of routine immunisation coverage. S Afr Med J. 2008;98:41-45.
15. Planting NS, Visser GL, Nicol MP, et al. Safety and efficacy of induced sputum in young children hospitalised with suspected pulmonary tuberculosis. Int J Tuberc Lung Dis. 2014;18:8-12.
16. Farrell DJ, Daggard G, Mukkur TK. Nested duplex PCR to detect Bordetella pertussis and Bordetella parapertussis and its application in diagnosis of pertussis in nonmetropolitan Southeast Queensland, Australia. J Clin Microbiol. 1999;37:606-610.
17. Tatti KM, Sparks KN, Boney KO, et al. Novel multitarget real-Time PCR assay for rapid detection of Bordetella species in clinical specimens. J Clin Microbiol. 2011;49:4059-4066.
18. Heininger U, Weibel D, Richard JL. Prospective nationwide surveillance of hospitalizations due to pertussis in children, 2006-2010. Pediatr Infect Dis J. 2014;33:147-151.
19. Cortese MM, Baughman AL, Zhang R, Srivastava PU, Wallace GS. Pertussis hospitalizations among infants in the United States, 1993 to 2004. Pediatrics. 2008;121:484-492.
20. Elliott E, McIntyre P, Ridley G, et al. National study of infants hospitalized with pertussis in the acellular vaccine era. Pediatr Infect Dis J. 2004;23:246-252.
21. Clemens J, Shin S, Ali M. New approaches to the assessment of vaccine herd protection in clinical trials. Lancet Infect Dis. 2011;11:482-487.
22. le Roux DM, Myer L, Nicol MP, et al. Incidence and severity of childhood pneumonia in the first year of life in a South African birth cohort: The Drakenstein Child Health Study. Lancet Glob Health. 2015;3:e95-e103.
23. Piedra PA, Mansbach JM, Jewell AM, et al. Bordetella pertussis is an uncommon pathogen in children hospitalized with bronchiolitis during the winter season. Pediatr Infect Dis J. 2015;34:566-570.
24. UNAIDS. Global Statistics. Fact Sheet 2014. Available at: http://www. unaids.org/sites/default/files/en/media/unaids/contentassets/documents/factsheet/2014/20140716-FactSheet-en.pdf. Accessed June 17, 2015.
25. Tejiokem MC, Gouandjika I, Béniguel L, et al. HIV-infected children living in Central Africa have low persistence of antibodies to vaccines used in the Expanded Program on Immunization. PLoS One. 2007;2:e1260.
26. Tejiokem MC, Njamkepo E, Gouandjika I, et al. Whole-cell pertussis vaccine induces low antibody levels in human immunodeficiency virus-infected children living in sub-Saharan Africa. Clin Vaccine Immunol. 2009;16:479-483.
27. Jones CE, Naidoo S, De Beer C, et al. Maternal HIV infection and antibody responses against vaccine-preventable diseases in uninfected infants. JAMA. 2011;305:576-584.
28. Kidzeru EB, Hesseling AC, Passmore JA, et al. In-utero exposure to maternal HIV infection alters T-cell immune responses to vaccination in HIVuninfected infants. AIDS. 2014;28:1421-1430.
29. Zar HJ, Hanslo D, Apolles P, et al. Induced sputum versus gastric lavage for microbiological confirmation of pulmonary tuberculosis in infants and young children: A prospective study. Lancet. 2005;365:130-134.
30. Altunaiji S, Kukuruzovic R, Curtis N, Massie J. Antibiotics for whooping cough (pertussis). Cochrane Database Syst Rev. 2007:Cd004404.
31. Tiwari T, Murphy TV, Moran J; National Immunization Program, CDC. Recommended antimicrobial agents for the treatment and postexposure prophylaxis of pertussis: 2005 CDC Guidelines. MMWR Recomm Rep. 2005;54(RR-14):1-16.
32. Ishiguro T, Takayanagi N, Yamaguchi S, et al. Etiology and factors contributing to the severity and mortality of community-Acquired pneumonia. Intern Med. 2013;52:317-324.
33. Cillóniz C, Ewig S, Ferrer M, et al. Community-Acquired polymicrobial pneumonia in the intensive care unit: Aetiology and prognosis. Crit Care. 2011;15:R209.
34. Hammitt LL, Kazungu S, Morpeth SC, et al. A preliminary study of pneumonia etiology among hospitalized children in Kenya. Clin Infect Dis. 2012;54(suppl 2):S190-S199.
35. Sligl WI, Asadi L, Eurich DT, et al. Macrolides and mortality in critically ill patients with community-Acquired pneumonia: A systematic review and meta-Analysis. Crit Care Med. 2014;42:420-432.
36. Kuster SP, Rudnick W, Shigayeva A, et al.; Toronto Invasive Bacterial Diseases Network. Previous antibiotic exposure and antimicrobial resistance in invasive pneumococcal disease: results from prospective surveillance. Clin Infect Dis. 2014;59:944-952.